Richard l. Love

Richard l. Love is a declared insider at 2 companies; the most frequent names are CTI Biopharma Corp and Parexel International Corp. Over a trading history stretching from 30 March 2016 to 29 September 2017, the count stands at 21 filings.

Sales make up the whole of the open-market record (16 sales, €113k). Other entries cover 2 share grants and 2 option exercises. Since January 2017: no purchases and 15 sales on the market.

On 4 October 2017 came the latest disclosure, a transaction in Parexel International Corp. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.